ORCA BIO

CA

Development of high-precision cell therapies for treating cancer and autoimmune disease

Filings
2
Firms Hired
1
Total Expenses
Years Active
2026–2026

Filings

YearFirmPeriodExpensesDoc
2026 BGR GOVERNMENT AFFAIRS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
2026 BGR GOVERNMENT AFFAIRS 2nd Quarter (Apr 1 - June 30)
Registration
Firms Hired
FirmFilingsExpenses
BGR GOVERNMENT AFFAIRS 2
Issue Areas